Pfizer Inc (MIL:1PFE)
€ 24.62 -0.33 (-1.32%) Market Cap: 140.00 Bil Enterprise Value: 193.63 Bil PE Ratio: 34.77 PB Ratio: 1.58 GF Score: 59/100

Pfizer Inc at Wells Fargo Healthcare Conference Transcript

Sep 08, 2022 / 01:10PM GMT
Mohit Bansal
Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst

Okay. Great. Thank you. Thank you, everyone, for joining us today. My name is Mohit Bansal. I'm one of the biopharma analysts here at Wells Fargo, and I have great pleasure to start with Dr. Dave Denton from Pfizer.

David M. Denton
Pfizer Inc. - CFO & Executive VP

I love it.

Mohit Bansal
Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst

And Chris Stevo from Pfizer. So Dave is the CFO of the Pfizer and he recently started in May of this year.

David M. Denton
Pfizer Inc. - CFO & Executive VP

Yes, exactly. Exactly.

Mohit Bansal
Wells Fargo Securities, LLC, Research Division - Senior Equity Analyst

And Chris, I think it is almost a year for you.

Christopher J. Stevo;
Pfizer Inc. - Senior VP & Chief IR Officer

Correct. Just over a year actually.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot